257 related articles for article (PubMed ID: 16527016)
1. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
Arikan OK; Tan FU; Kendi T; Koc C
J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
[TBL] [Abstract][Full Text] [Related]
2. The use of botulinum toxin type A in aesthetic mandibular contouring.
Kim NH; Chung JH; Park RH; Park JB
Plast Reconstr Surg; 2005 Mar; 115(3):919-30. PubMed ID: 15731696
[TBL] [Abstract][Full Text] [Related]
3. Effects of botulinum toxin type A on contouring of the lower face.
Choe SW; Cho WI; Lee CK; Seo SJ
Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
[TBL] [Abstract][Full Text] [Related]
4. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
Kim HJ; Yum KW; Lee SS; Heo MS; Seo K
Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
6. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
Ahn KY; Kim ST
Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
[TBL] [Abstract][Full Text] [Related]
7. The medical management of masseteric hypertrophy with botulinum toxin.
Finn S; Ryan P; Sleeman D
J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for masseter hypertrophy.
Fedorowicz Z; van Zuuren EJ; Schoones J
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
[TBL] [Abstract][Full Text] [Related]
9. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.
Mandel L; Tharakan M
J Oral Maxillofac Surg; 1999 Aug; 57(8):1017-9. PubMed ID: 10437733
[No Abstract] [Full Text] [Related]
10. Botulinum toxin type A treatment for contouring of the lower face.
Park MY; Ahn KY; Jung DS
Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
[TBL] [Abstract][Full Text] [Related]
11. Discussion on The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
Hwang K
Dermatol Surg; 2014 Dec; 40(12):1340-1. PubMed ID: 25380090
[No Abstract] [Full Text] [Related]
12. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
[TBL] [Abstract][Full Text] [Related]
13. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB
J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH
J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
[TBL] [Abstract][Full Text] [Related]
15. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
Baş B; Ozan B; Muğlali M; Celebi N
Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
[TBL] [Abstract][Full Text] [Related]
16. Bilateral hypertrophy of masseteric and temporalis muscles, our fifteen patients and review of literature.
Graziano P; Dell'Aversana Orabona G; Astarita F; Ponzo LM; Nunziata R; Salzano G; Maglitto F; Solari D; Santella A; Cappabianca M; Iaconetta G; Califano L
Eur Rev Med Pharmacol Sci; 2016; 20(1):7-11. PubMed ID: 26813447
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
To EW; Ahuja AT; Ho WS; King WW; Wong WK; Pang PC; Hui AC
Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
Gaofeng L; Jun T; Bo P; Bosheng Z; Qian Z; Dongping L
J Plast Reconstr Aesthet Surg; 2010 Dec; 63(12):2026-31. PubMed ID: 20116356
[TBL] [Abstract][Full Text] [Related]
19. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
Kaya B; Apaydin N; Loukas M; Tubbs RS
J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
[TBL] [Abstract][Full Text] [Related]
20. Nonsurgical reshaping of the lower face.
Liew S; Dart A
Aesthet Surg J; 2008; 28(3):251-7. PubMed ID: 19083534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
